Besides its use for noninvasive functional brain PET imaging to detect changes in neurodegenerative diseases as analyzed before, the present data also support the potential application as an additional tool for multiple diagnostic tumor imaging to detect the right patients with Trk protein expression in cancers and to select them for specific Trk inhibitor therapy. The gene discussed is TPM3; the disease is neurodegenerative disease.